Why Patent Protection is key to Commercialising Repurposed Drugs
April 05, 2021
Why Patent Protection is key to Commercialising Repurposed Drugs | Live Webinar
- MaryAnne Armstrong, Ph.D.
Without patent protection, efforts to commercialise a repurposed drug have little chance for a reasonable return and are unlikely to attract outside investment. Repurposing drugs can be extremely fruitful for companies as long as proper patent protection is in place. There are a few barriers to consider when trying to patent protect repurposed drugs:
- The issue of novelty
- An obviousness rejection and the use of “unexpected results”
- “Composition of matter” patent vs “method of use patent”
Join this panel discussion to discuss these issues, and how best to maximise your return on repurposed drugs.